Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,069,395
+$1,689,218 QoQ
Shares Held
16,882
+368.0% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#141
of 343 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Derivatives in PTGX
reported options exposure · as of Jun 30, 2026CallValue
$1,250,316
CallShares
10,200
PutValue
$281,934
PutShares
2,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names. PTGX ranks #63 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in PTGX
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,069,395 | 16,882 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $281,934 | 2,300 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $1,250,316 | 10,200 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $4,479,500 | 42,500 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $380,177 | 3,607 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,996,372 | 34,307 | Shares | Defined | 2026-02-12 | |
| 2025-12-31 | $6,078,864 | 69,600 | Call | Defined | 2026-02-12 | |
| 2025-09-30 | $1,713,894 | 25,800 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $2,945,437 | 44,339 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $486,376 | 8,800 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $1,121,981 | 20,300 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $9,347,988 | 193,300 | Shares | Defined | 2025-05-19 | |
| 2025-03-31 | $2,456,688 | 50,800 | Put | Defined | 2025-05-19 | |
| 2025-03-31 | $4,884,360 | 101,000 | Call | Defined | 2025-05-19 | |
| 2024-12-31 | $420,740 | 10,900 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $2,375,867 | 61,551 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,478,610 | 32,858 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $5,866,625 | 169,311 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $2,351,140 | 81,270 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $1,672,307 | 72,931 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $642,280 | 38,506 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $602,364 | 21,809 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,292,968 | 56,216 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $609,770 | 55,891 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $86,736 | 10,289 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $300,231 | 37,956 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $726,976 | 30,700 | Put | Defined | 2022-05-17 | |
| 2021-12-31 | $2,612,743 | 76,396 | Shares | Defined | 2022-02-15 | |
| 2021-12-31 | $1,309,860 | 38,300 | Call | Defined | 2022-02-15 | |
| 2021-09-30 | $1,025,172 | 57,854 | Shares | Defined | 2021-11-16 | |
| 2020-12-31 | $291,775 | 14,473 | Shares | Defined | 2021-02-17 | |
| 2020-09-30 | $259,389 | 13,268 | Shares | Defined | 2020-11-17 | |
| No filing history on record for this holder in this stock. | ||||||